Skip to main content
Top
Published in: Rheumatology International 9/2006

01-07-2006 | Case Report

A case of overlap syndrome with rheumatoid arthritis, systemic lupus erythematosus, systemic sclerosis and secondary sjögren’s syndrome

Authors: Nuran Turkcapar, Umit Olmez, Didem Ozer, Nursen Duzgun, Murat Duman

Published in: Rheumatology International | Issue 9/2006

Login to get access

Abstract

We report an unusual case of overlap syndrome that had the coexistence of five autoimmune diseases. A 45-year-old woman initially developed seropositive erosive rheumatoid arthritis (RA) 11 years ago. She then developed progressive systemic sclerosis (PSS) (including pulmonary hypertension, esophageal dysfunction, cardiac involvement and sclerodactilitis), systemic lupus erythematosus (SLE) (including photosensitivity, nephritis, leukopenia, lymphopenia, thrombocytopenia and Coombs positive hemolytic anemia and positive anti-dsDNA), and secondary Sjögren’s syndrome (SSS) in the last 7 years before she was admitted to our clinic. The patient fulfilled classification criteria for RA, SLE, PSS and SSS, as determined by American College of Rheumatology. Hypothyroidism with positive autoantibodies due to Hashimoto’s thyroiditis, the beginning of which could not be defined, was coexistent with this overlap syndrome. In the literature, although overlap syndromes in different combinations were reported, we very rarely observed a complex case like this patient. In our opinion, this is the first well-documented case of RA, PSS, SLE, SSS and Hashimoto’s thyroiditis existing together in the same patient. Although immunosuppressive therapy was administered, the disease rapidly deteriorated and the patient died.

Literature
  1. Rechlin M (1997) Systemic rheumatic diseases: undifferentiated connective tissue disease, overlap syndromes, and mixed connective tissue disease. In: Koopman WJ (eds) arthritis and allied conditions a text book of rheumatology. William & Wilkins, Baltimore pp 1445–1454
  2. Maddison PJ (2000) Mixed connective tissue disease: overlap syndromes. Bailliere’s Best Pract Res Clin Rheumatol 14:111–124View ArticlePubMed
  3. Jablonska S, Blaszczyk M (1999) Scleroderma overlap syndromes. Adv Exp Med Biol 455:85–92PubMed
  4. Akiyama Y, Suzuki T, Tanaka M et al. A case of mixed connective tissue disease developed into overlap syndrome of progressive systemic sclerosis, systemic lupus erythematosus, polymyositis and Sjögren’s syndrome. Arerugi 39:542–547
  5. Gendi N, Gordon T, Taner SB, Black CM (1992) The evolution of a case of overlap syndrome with systemic sclerosis, rheumatoid arthritis and systemic lupus erythematosus. Rheumatol (Oxford) 31:783–786View Article
  6. Horiki T, Moriuchi J, Takaya M et al (1999) The coexistence of systemic sclerosis and rheumatoid arthritis in five patients. Arthritis Rheum 39:152–156View Article
  7. Soriano ER, McHugh NJ (2004) Overlap syndromes in adults and children. Oxford text book of rheumatology, 3rd edn. In: Isenberg DA, Maddison PJ, Woo P, Glass D, Breedveld FC (eds) Oxford University Press, New York, pp 998–1010
  8. Jury EC, D’Cruz D, Morrow WJW (2001). Autoantibodies and overlap syndromes in autoimmune rheumatic disease. J Clin Pathol 54:340–347View ArticlePubMed
  9. Sharp GC, Irwin WS, May CH et al (1976) Association of antibodies to ribonucleoprotein and Sm antigens with connective tissue disease, systemic lupus erythematosus, and other rheumatic diseases. NEJM 295:1149–1154PubMed
  10. Black CM, Maddison PJ, Welsh KI, Bernstein R, Woodrow JC, Pereira RS (1988) HLA and immunoglobulin allotypes in mixed connective tissue disease. Arthritis Rheum 31:131–135PubMedView Article
Metadata
Title
A case of overlap syndrome with rheumatoid arthritis, systemic lupus erythematosus, systemic sclerosis and secondary sjögren’s syndrome
Authors
Nuran Turkcapar
Umit Olmez
Didem Ozer
Nursen Duzgun
Murat Duman
Publication date
01-07-2006
Publisher
Springer-Verlag
Published in
Rheumatology International / Issue 9/2006
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-005-0084-1

Other articles of this Issue 9/2006

Rheumatology International 9/2006 Go to the issue